Loading...
Uploaded by ETnow on Feb 9, 2010
Templeton, which owns 10% stake in Taro, has withdrawn from Taro's appeal against Sun Pharma.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)